Number of shares outstanding for Myriad Genetics (MYGN)

Number of shares outstanding as of December 2025 : 93,100,000

According to Myriad Genetics's latest financial reports and stock price the company's current number of shares outstanding is 93,100,000. At the end of 2025 the company had 93,100,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Myriad Genetics from 2009 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	93.1 M	2.2%
2024	91.1 M	5.81%
2023	86.1 M	5.64%
2022	81.5 M	2%
2021	79.9 M	6.11%
2020	75.3 M	1.21%
2019	74.4 M	0.27%
2018	74.2 M	7.07%
2017	69.3 M	1.61%
2016	68.2 M	-3.26%
2015	70.5 M	-2.71%
2014	72.46 M	-3.47%
2013	75.07 M	-8.11%
2012	81.69 M	-3.32%
2011	84.49 M	-7.68%
2010	91.52 M	-4.93%
2009	96.27 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Bio-Rad Laboratories BIO	26,923,000	-71.08%	🇺🇸 USA
Exact Sciences EXAS	189,262,000	103.29%	🇺🇸 USA
Biocept BIOC	1,036,529	-98.89%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	192,032,000	106.26%	🇺🇸 USA
Abbott Laboratories ABT	1,738,871,947	1,767.75%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions